EMI (Encore Medical) Total Operating Expense: $1.26 Mil (TTM As of Dec. 2025)


What is Encore Medical Total Operating Expense?

Encore Medical EMI Total Operating Expense is $1.26 Mil as of Dec. 2025.

Encore Medical's Total Operating Expense for the three months ended in Dec. 2025 was $0.96 Mil. Encore Medical's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $1.26 Mil.

Encore Medical Total Operating Expense Related Terms

Encore Medical Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Encore Medical's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Total Operating Expense Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
Total Operating Expense
1.89 2.54 1.87

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial 0.90 0.91 0.00 0.30 0.96

Encore Medical Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.26 Mil mean?
Encore Medical (EMI) has a Total Operating Expense of $1.26 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Encore Medical and its competitors.
Is Encore Medical's Total Operating Expense too high?
Encore Medical's current Total Operating Expense is $1.26 Mil.
How does Encore Medical's Total Operating Expense compare to ?
Encore Medical's Total Operating Expense of $1.26 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Encore Medical and its competitors. Encore Medical's current Total Operating Expense is $1.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current Total Operating Expense of $1.26 Mil. The current Total Operating Expense is $1.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Encore Medical (EMI), the current Total Operating Expense is $1.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).